WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal

Detalles Bibliográficos
Autores principales: Kruger, Donna, Prathapan, Praveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439010/
https://www.ncbi.nlm.nih.gov/pubmed/32839756
http://dx.doi.org/10.1016/j.jtauto.2020.100062
_version_ 1783572908419842048
author Kruger, Donna
Prathapan, Praveen
author_facet Kruger, Donna
Prathapan, Praveen
author_sort Kruger, Donna
collection PubMed
description This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal
format Online
Article
Text
id pubmed-7439010
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74390102020-08-20 WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic Kruger, Donna Prathapan, Praveen J Transl Autoimmun Article This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal Published by Elsevier B.V. 2020-08-20 /pmc/articles/PMC7439010/ /pubmed/32839756 http://dx.doi.org/10.1016/j.jtauto.2020.100062 Text en © 2020 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kruger, Donna
Prathapan, Praveen
WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic
title WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic
title_full WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic
title_fullStr WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic
title_full_unstemmed WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic
title_short WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic
title_sort withdrawn: azithromycin: the first broad-spectrum therapeutic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439010/
https://www.ncbi.nlm.nih.gov/pubmed/32839756
http://dx.doi.org/10.1016/j.jtauto.2020.100062
work_keys_str_mv AT krugerdonna withdrawnazithromycinthefirstbroadspectrumtherapeutic
AT prathapanpraveen withdrawnazithromycinthefirstbroadspectrumtherapeutic

Ejemplares similares